Quantcast

Latest Type 1 hypersensitivity Stories

2014-10-20 08:30:43

TARRYTOWN, N.Y. and PARIS, Oct. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that the first patients have been dosed in a Phase 3 clinical study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, in adults with moderate-to-severe atopic dermatitis (AD) that is not adequately controlled with topical AD medications. LIBERTY AD CHRONOS, the first trial in the Phase 3 clinical...

2014-10-14 20:23:15

-New Yorkers with Severe Lung Diseases, Here is Your Rescue! SEOUL, South Korea, Oct. 14, 2014 /PRNewswire/ -- "About 123,000 patients with atopic dermatitis, rhinitis, and asthma and 32,000 patients with pulmonary emphysema, bronchiectasis, and pulmonary fibrosis have been cured." http://photos.prnewswire.com/prnvar/20141014/151916 There is a Korean medicine doctor who has cured hundred thousands of lives of patients with chronic allergic conditions, only with Korean medicine. He...

2014-10-13 12:27:31

DALLAS, October 13, 2014 /PRNewswire/ -- The EpiCast Report: Allergic Conjunctivitis - Epidemiology Forecast to 2023 is a 30 pages market research published in October 2014. Allergic conjunctivitis could be categorized as seasonal allergic conjunctivitis (SAC), which is the most common one, perennial allergic conjunctivitis (PAC), giant papillary conjunctivitis (GPC), vernal keratoconjunctivitis (VKC), and atopic keratoconjunctivitis (AKC) (Calonge, 1999). SAC and PAC...

2014-10-13 08:27:05

Aratana to Develop CRTH2 Antagonist for Atopic Dermatitis in Companion Animals KANSAS CITY, Kan. and OXFORD, United Kingdom, Oct. 13, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, and Atopix Therapeutics Ltd., a clinical stage company focused on innovative oral therapeutics for allergic diseases, today announced the completion...

2014-10-02 16:26:37

ROUND ROCK, Texas, Oct. 2, 2014 /PRNewswire/ -- Antibiotic options are becoming limited by drug-resistant pathogens, creating a "serious domestic and international challenge to human and animal health, national security and the economy," said John Holdren, director of the White House Office of Science and Technology Policy at a September press conference. In laying out the White House's plan to fight antibiotic misuse, Mr. Holdren said that up to half of all antibiotics prescribed are not...

2014-10-01 08:31:01

-- Today is the first ever International Urticaria Day, an international event to increase urticaria awareness and improve care around the globe and let people living with urticaria know they are not alone -- Skin Impressions campaign aims to break down barriers preventing people suffering from severe skin diseases like chronic idiopathic urticaria (CIU) from living lives to the fullest -- CIU is an unpredictable skin disease characterized by...

2014-09-30 00:21:34

TARRYTOWN, N.Y. and PARIS, Sept. 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids. "These data suggest the potential of...

2014-09-18 23:09:52

Margo Weaver, a Florida-based author, has released a new book aimed at helping children suffering from eczema to become more comfortable in their skin. APOPKA, Fla (PRWEB) September 18, 2014 According to the National Eczema Association, there are 30 million Americans who suffer from eczema, with many of them being children. In fact, they report that most people with the condition are first diagnosed as babies and children. The millions of children who have it often struggle with the...

2014-08-25 08:24:15

Video Will Aim to Address Gaps in Knowledge About Life-Threatening (Severe) Allergies PITTSBURGH, Aug. 25, 2014 /PRNewswire/ -- Mylan Specialty, the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL), and pro football player and EpiPen(®) (epinephrine) Auto-Injector spokesperson Adrian Peterson today announced the three winners of the Ready2Go(TM) MVP Draft, a nationwide search to find kids who have potentially life-threatening (severe) allergies and are prepared...

2014-07-24 16:26:32

OTTAWA, July 24, 2014 The Canadian Society of Allergy and Clinical Immunology (CSACI) would like to comment on the death of Mrs. Lucie Roussel, Mayor of La Prairie, on Sunday. As previously reported, Mrs. Roussel stepped on a wasp nest and was stung multiple times. Unfortunately, the autopsy report is not yet available. It is thought that Mrs. Roussel died from a toxic reaction to the stings which usually requires at least 50 stings, or anaphylaxis which can occur after one sting....


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related